Trial intelligence / Profile preview

Toutongning capsule for migraine

ChiCTR-IPR-15007058Phase 4Completed

Sponsor
Chinese PLA General Hospital
Start
Oct 2013
Countries
1
01

Overview

Phase 4, randomised, double-blind trial of Toutongning in migraine (2 arms), sponsored by Chinese PLA General Hospital. Primary endpoints: Brain CT, Vital signs and 7 more. Started Oct 2013; status: completed.

02

Drugs

Toutongning
03

Conditions

migraine

Beyond the preview

Go deeper on ChiCTR-IPR-15007058.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on ChiCTR-IPR-15007058.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call